1IA
1620 Investment Advisors’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $695K | Buy |
9,944
+206
| +2% | +$14.4K | 0.49% | 58 |
|
|
2025
Q1 | $716K | Buy |
9,738
+64
| +0.7% | +$4.7K | 0.55% | 44 |
|
|
2024
Q4 | $634K | Buy |
9,674
+28
| +0.3% | +$1.84K | 0.48% | 58 |
|
|
2024
Q3 | $752K | Sell |
9,646
-34
| -0.4% | -$2.65K | 0.54% | 45 |
|
|
2024
Q2 | $755K | Buy |
9,680
+187
| +2% | +$14.6K | 0.58% | 41 |
|
|
2024
Q1 | $643K | Sell |
9,493
-424
| -4% | -$28.7K | 0.65% | 48 |
|
|
2023
Q4 | $668K | Buy |
9,917
+28
| +0.3% | +$1.89K | 0.73% | 41 |
|
|
2023
Q3 | $670K | Sell |
9,889
-31
| -0.3% | -$2.1K | 0.76% | 36 |
|
|
2023
Q2 | $710K | Buy |
9,920
+9
| +0.1% | +$644 | 0.77% | 38 |
|
|
2023
Q1 | $688K | Sell |
9,911
-132
| -1% | -$9.16K | 0.83% | 39 |
|
|
2022
Q4 | $681K | Buy |
10,043
+194
| +2% | +$13.2K | 0.82% | 43 |
|
|
2022
Q3 | $540K | Buy |
9,849
+41
| +0.4% | +$2.25K | 0.8% | 43 |
|
|
2022
Q2 | $648K | Buy |
9,808
+617
| +7% | +$40.8K | 0.89% | 35 |
|
|
2022
Q1 | $535K | Hold |
9,191
| – | – | 0.58% | 65 |
|
|
2021
Q4 | $535K | Buy |
+9,191
| New | +$535K | 0.6% | 62 |
|